CARsgen Therapeutics Holdings Ltd
HKEX:2171

Watchlist Manager
CARsgen Therapeutics Holdings Ltd Logo
CARsgen Therapeutics Holdings Ltd
HKEX:2171
Watchlist
Price: 8.42 HKD -3.11%
Market Cap: 4.8B HKD
Have any thoughts about
CARsgen Therapeutics Holdings Ltd?
Write Note

Intrinsic Value

CARsgen Therapeutics Holdings Ltd's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one CARsgen Therapeutics Holdings Ltd stock under the Base Case scenario is 13.12 HKD. Compared to the current market price of 8.42 HKD, CARsgen Therapeutics Holdings Ltd is Undervalued by 36%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
13.12 HKD
Undervaluation 36%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
CARsgen Therapeutics Holdings Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for CARsgen Therapeutics Holdings Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about CARsgen Therapeutics Holdings Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

8.42 HKD
-3.11%
-3.11%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

CARsgen Therapeutics Holdings Ltd
CN
Biotechnology
Market Cap
4.8B HKD
IPO
Jun 18, 2021
Employees
573
China
Market Cap
4.8B HKD
Industry
Biotechnology
IPO
Jun 18, 2021
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about CARsgen Therapeutics Holdings Ltd

Provide an overview of the primary business activities
of CARsgen Therapeutics Holdings Ltd.

What unique competitive advantages
does CARsgen Therapeutics Holdings Ltd hold over its rivals?

What risks and challenges
does CARsgen Therapeutics Holdings Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for CARsgen Therapeutics Holdings Ltd.

Provide P/S
for CARsgen Therapeutics Holdings Ltd.

Provide P/E
for CARsgen Therapeutics Holdings Ltd.

Provide P/OCF
for CARsgen Therapeutics Holdings Ltd.

Provide P/FCFE
for CARsgen Therapeutics Holdings Ltd.

Provide P/B
for CARsgen Therapeutics Holdings Ltd.

Provide EV/S
for CARsgen Therapeutics Holdings Ltd.

Provide EV/GP
for CARsgen Therapeutics Holdings Ltd.

Provide EV/EBITDA
for CARsgen Therapeutics Holdings Ltd.

Provide EV/EBIT
for CARsgen Therapeutics Holdings Ltd.

Provide EV/OCF
for CARsgen Therapeutics Holdings Ltd.

Provide EV/FCFF
for CARsgen Therapeutics Holdings Ltd.

Provide EV/IC
for CARsgen Therapeutics Holdings Ltd.

Show me price targets
for CARsgen Therapeutics Holdings Ltd made by professional analysts.

What are the Revenue projections
for CARsgen Therapeutics Holdings Ltd?

How accurate were the past Revenue estimates
for CARsgen Therapeutics Holdings Ltd?

What are the Net Income projections
for CARsgen Therapeutics Holdings Ltd?

How accurate were the past Net Income estimates
for CARsgen Therapeutics Holdings Ltd?

What are the EPS projections
for CARsgen Therapeutics Holdings Ltd?

How accurate were the past EPS estimates
for CARsgen Therapeutics Holdings Ltd?

What are the EBIT projections
for CARsgen Therapeutics Holdings Ltd?

How accurate were the past EBIT estimates
for CARsgen Therapeutics Holdings Ltd?

Compare the revenue forecasts
for CARsgen Therapeutics Holdings Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of CARsgen Therapeutics Holdings Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of CARsgen Therapeutics Holdings Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of CARsgen Therapeutics Holdings Ltd compared to its peers.

Compare the P/E ratios
of CARsgen Therapeutics Holdings Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing CARsgen Therapeutics Holdings Ltd with its peers.

Analyze the financial leverage
of CARsgen Therapeutics Holdings Ltd compared to its main competitors.

Show all profitability ratios
for CARsgen Therapeutics Holdings Ltd.

Provide ROE
for CARsgen Therapeutics Holdings Ltd.

Provide ROA
for CARsgen Therapeutics Holdings Ltd.

Provide ROIC
for CARsgen Therapeutics Holdings Ltd.

Provide ROCE
for CARsgen Therapeutics Holdings Ltd.

Provide Gross Margin
for CARsgen Therapeutics Holdings Ltd.

Provide Operating Margin
for CARsgen Therapeutics Holdings Ltd.

Provide Net Margin
for CARsgen Therapeutics Holdings Ltd.

Provide FCF Margin
for CARsgen Therapeutics Holdings Ltd.

Show all solvency ratios
for CARsgen Therapeutics Holdings Ltd.

Provide D/E Ratio
for CARsgen Therapeutics Holdings Ltd.

Provide D/A Ratio
for CARsgen Therapeutics Holdings Ltd.

Provide Interest Coverage Ratio
for CARsgen Therapeutics Holdings Ltd.

Provide Altman Z-Score Ratio
for CARsgen Therapeutics Holdings Ltd.

Provide Quick Ratio
for CARsgen Therapeutics Holdings Ltd.

Provide Current Ratio
for CARsgen Therapeutics Holdings Ltd.

Provide Cash Ratio
for CARsgen Therapeutics Holdings Ltd.

What is the historical Revenue growth
over the last 5 years for CARsgen Therapeutics Holdings Ltd?

What is the historical Net Income growth
over the last 5 years for CARsgen Therapeutics Holdings Ltd?

What is the current Free Cash Flow
of CARsgen Therapeutics Holdings Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for CARsgen Therapeutics Holdings Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
CARsgen Therapeutics Holdings Ltd

Balance Sheet Decomposition
CARsgen Therapeutics Holdings Ltd

Current Assets 1.7B
Cash & Short-Term Investments 1.7B
Receivables 23.4m
Other Current Assets 63.7m
Non-Current Assets 362.8m
PP&E 339.9m
Intangibles 6.5m
Other Non-Current Assets 16.3m
Current Liabilities 183.7m
Accrued Liabilities 105.2m
Other Current Liabilities 78.5m
Non-Current Liabilities 421.5m
Long-Term Debt 179.9m
Other Non-Current Liabilities 241.6m
Efficiency

Earnings Waterfall
CARsgen Therapeutics Holdings Ltd

Revenue
6.3m CNY
Cost of Revenue
-4.7m CNY
Gross Profit
1.6m CNY
Operating Expenses
-740.2m CNY
Operating Income
-738.6m CNY
Other Expenses
43.7m CNY
Net Income
-694.9m CNY

Free Cash Flow Analysis
CARsgen Therapeutics Holdings Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

CARsgen Therapeutics Holdings Ltd's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

20/100
Profitability
Score

CARsgen Therapeutics Holdings Ltd's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

CARsgen Therapeutics Holdings Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
53/100
Solvency
Score

CARsgen Therapeutics Holdings Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
CARsgen Therapeutics Holdings Ltd

Wall Street analysts forecast CARsgen Therapeutics Holdings Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CARsgen Therapeutics Holdings Ltd is 9.89 HKD with a low forecast of 7.98 HKD and a high forecast of 12.08 HKD.

Lowest
Price Target
7.98 HKD
5% Downside
Average
Price Target
9.89 HKD
18% Upside
Highest
Price Target
12.08 HKD
43% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CARsgen Therapeutics Holdings Ltd?

Click here to dive deeper.

Dividends

CARsgen Therapeutics Holdings Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for CARsgen Therapeutics Holdings Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one CARsgen Therapeutics Holdings Ltd stock?

The intrinsic value of one CARsgen Therapeutics Holdings Ltd stock under the Base Case scenario is 13.12 HKD.

Is CARsgen Therapeutics Holdings Ltd stock undervalued or overvalued?

Compared to the current market price of 8.42 HKD, CARsgen Therapeutics Holdings Ltd is Undervalued by 36%.

Back to Top